Technical Analysis for WVE - WAVE Life Sciences Ltd.

Grade Last Price % Change Price Change
grade D 8.47 1.80% 0.15
WVE closed up 1.8 percent on Wednesday, February 26, 2020, on 39 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Flat
Historical WVE trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
New Uptrend Bullish 1.80%
Wide Bands Range Expansion 1.80%
Upper Bollinger Band Walk Strength 2.92%
Wide Bands Range Expansion 2.92%
Overbought Stochastic Strength 2.92%
Gapped Down Weakness 2.92%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.72%
Upper Bollinger Band Walk Strength -4.72%
Weak + Overbought Other -4.72%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

WAVE Life Sciences Pte. Ltd., a preclinical biopharmaceutical company, designs, develops, and commercializes nucleic acid therapeutic candidates. The company is developing nucleic acid therapeutics that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. Its advanced therapeutic programs are in Huntington's disease, Duchenne muscular dystrophy (DMD), and inflammatory bowel disease (IBD). In Huntington's disease, it has programs targeting HTT SNP-1 and HTT SNP-2; in DMD, targeting Exon 51; and in IBD, targeting SMAD7. The company also has product candidates in its programs targeting HTT SNP-1 and Exon 51. In addition, it has late-stage discovery programs in epidermolysis bullosa simplex, targeting KRT14 SNP-1 and KRT14 SNP-2, as well as in DMD, focuses on an additional DMD target, AcRIIb. The company was founded in 2012 and is based in Singapore.
Rare Diseases Medical Genetics Inflammatory Bowel Disease Muscular Dystrophy Huntington's Disease Duchenne Muscular Dystrophy Genetic Genealogy Genodermatoses Cytoskeleton Dystrophin Ibd SNP

Is WVE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 48.64
52 Week Low 6.89
Average Volume 1,159,994
200-Day Moving Average 20.99
50-Day Moving Average 9.96
20-Day Moving Average 7.93
10-Day Moving Average 8.46
Average True Range 0.67
ADX 28.01
+DI 25.68
-DI 25.37
Chandelier Exit (Long, 3 ATRs ) 7.84
Chandelier Exit (Short, 3 ATRs ) 8.90
Upper Bollinger Band 9.28
Lower Bollinger Band 6.58
Percent B (%b) 0.7
BandWidth 34.02
MACD Line -0.48
MACD Signal Line -0.86
MACD Histogram 0.3782
Fundamentals Value
Market Cap 235.13 Million
Num Shares 27.8 Million
EPS -3.35
Price-to-Earnings (P/E) Ratio -2.53
Price-to-Sales 250.07
Price-to-Book 3.20
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.27
Resistance 3 (R3) 9.20 8.88 9.13
Resistance 2 (R2) 8.88 8.67 8.91 9.09
Resistance 1 (R1) 8.67 8.55 8.78 8.74 9.04
Pivot Point 8.35 8.35 8.40 8.38 8.35
Support 1 (S1) 8.14 8.14 8.25 8.21 7.90
Support 2 (S2) 7.82 8.02 7.85 7.85
Support 3 (S3) 7.61 7.82 7.81
Support 4 (S4) 7.68